Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Sanjay S. Reddy, MD, Joins Fox Chase Cancer Center’s Department of Surgery
PHILADELPHIA, PA (August 19, 2014)—Sanjay S. Reddy, MD – a surgeon trained in traditional, as well as laparoscopic and robotic techniques – has joined Fox Chase Cancer Center’s Department of Surgery after completing a two-year fellowship at the Center. He specializes in the care of patients with colorectal, liver, pancreatic, stomach cancers, melanoma and sarcomas.
Dr. Reddy, who completed his residency in general surgery at Beth Israel Medical Center in New York, has a particular research interest in colorectal malignancies – specifically the use of national databases to assess the accuracy of clinical staging – and vascular resectability staging of pancreatic cancer.
“Medicine has always been a family oriented field for me, with my father being a surgeon, and mother an anesthesiologist,” says Dr. Reddy. “I take great pride in offering compassion and honesty in formulating individualized treatment plans for every patient and their family.”
“The benefit of working at an NCI-designated cancer center is that we are able to offer many innovative strategies in treating all types of cancers,” Dr. Reddy adds. “Whether through a national clinical trial or particular surgical technique, we are able to optimize patient care to the individual.”